HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acute nonperforating appendicitis. Efficacy of brief antibiotic prophylaxis.

Abstract
A prospective, randomized, double-blind clinical study was performed to determine the efficacy of perioperative systemic antibiotics in preventing infection after appendectomy for acute nonperforating appendicitis. One hundred three patients received three doses of either placebo (saline, n = 52) or cefoxitin sodium (n = 51). The two groups were similar with regard to age distribution, sex ratio, duration of operation, pathologic condition of appendix, and hospital stay. Postoperative wound infections were detected in 9.6% of the placebo-treated patients, whereas none occurred in the cefoxitin group. All but one infection appeared after discharge. Cost analysis identified a net savings of $ 84 per patient with the use of prophylactic antibiotics. Septic morbidity after appendectomy for nonperforating appendicitis is significantly reduced by systemic antibiotics, and brief administration of a single broad-spectrum agent (cefoxitin) is effective prophylaxis.
AuthorsR E Winslow, R E Dean, J W Harley
JournalArchives of surgery (Chicago, Ill. : 1960) (Arch Surg) Vol. 118 Issue 5 Pg. 651-5 (May 1983) ISSN: 0004-0010 [Print] United States
PMID6404238 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Cefoxitin
Topics
  • Adolescent
  • Adult
  • Aged
  • Appendicitis (complications, drug therapy)
  • Cefoxitin (administration & dosage)
  • Child
  • Child, Preschool
  • Cost-Benefit Analysis
  • Double-Blind Method
  • Female
  • Humans
  • Intraoperative Care
  • Male
  • Middle Aged
  • Postoperative Complications (prevention & control)
  • Prospective Studies
  • Random Allocation
  • Wound Infection (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: